ABSTRACT
Background In many African countries, there are limited representative data on HIV/AIDS mortality. We tested whether such data could be collected during household surveys periodically conducted in most African countries.
Methods We added HIV questions to the module on adult and maternal mortality used in Demographic and Health Surveys. We conducted a validation study of the data generated by these questions in northern Malawi. We randomly assigned men and women aged 15–59 years old to a face-to-face interview or audio computer-assisted self-interviewing (ACASI). We compared survey reports of adult deaths to prospective data on mortality and HIV collected by the Karonga Health and Demographic Surveillance Site. We calculated the sensitivity and specificity of survey data in recording the HIV status of deceased siblings of respondents. We adjusted for partial verification bias using multiple imputations.
Results We interviewed 535 participants, who reported 885 deaths at ages 15 and older. The added HIV questions yielded largely complete data on the HIV status of respondents’ deceased siblings, particularly those who died recently. The adjusted sensitivity of survey data on HIV status of the deceased was high in both study groups (0.78–0.82). There were few false positive reports of the HIV status of deceased siblings (specificity = 0.96–0.98). ACASI did not improve the accuracy of survey data, but it required more time to collect mortality reports. Asking the HIV questions only took 0.4 minute (≈25 seconds) per deceased sibling in face-to-face interviews.
Conclusions Adding HIV questions to mortality questionnaires used in household surveys yields accurate data on the HIV status of deceased adults. These new data could aid in tracking progress towards global HIV elimination targets.
MEIRU – LSHTM – JHU Partnership for improving adult mortality data1,2
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This project was supported by R21AI127286 and R01HD088516.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol was approved by the IRBs of the Bloomberg School of Public Health at Johns Hopkins University; the London School of Hygiene and Tropical Medicine; and the National Health Science Research Committee (NHSRC) in Malawi.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All study data are available upon requests, and will be made available shortly after preparation of a repository.
